Baohuoside 1

Baohuoside 1 is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 477 references associated with Baohuoside 1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Baohuoside 1

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Baohuoside 1

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Total 8

All references with Baohuoside 1

Download all related citations
Per page 10 20 50 100 | Total 93
Authors Title Published Journal PubMed Link
He L et al. Icariside II ameliorates ibotenic acid-induced cognitive impairment and apoptotic response via modulation of MAPK pathway in rats. 2018 Phytomedicine pmid:29519323
Wang ZD et al. Reversal of multidrug resistance by icaritin in doxorubicin-resistant human osteosarcoma cells. 2018 Chin J Nat Med pmid:29425587
Fu S et al. Icariside II attenuates myocardial fibrosis by inhibiting nuclear factor-κB and the TGF-β1/Smad2 signalling pathway in spontaneously hypertensive rats. 2018 Biomed. Pharmacother. pmid:29421583
Yang L et al. Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling. 2018 Mol Med Rep pmid:29286100
Peng YG and Zhang L Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma. 2018 Pharm Biol pmid:29260980
Wu Y et al. IcarisideII improves left ventricular remodeling in spontaneously hypertensive rats by inhibiting the ASK1-JNK/p38 signaling pathway. 2018 Eur. J. Pharmacol. pmid:29175071
Liu XY et al. Icariside II attenuates cardiac remodeling via AMPKα2/mTORC1 in vivo and in vitro. 2018 J. Pharmacol. Sci. pmid:30241784
Liu S et al. Icariside II, a Phosphodiesterase-5 Inhibitor, Attenuates Beta-Amyloid-Induced Cognitive Deficits via BDNF/TrkB/CREB Signaling. 2018 Cell. Physiol. Biochem. pmid:30196289
Wu T et al. Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents. 2018 Molecules pmid:30150543
Lei H et al. Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells. 2018 Drug Des Devel Ther pmid:29942117

Table of Content